Albert Oriol

Publishing 2016

Is this you? Claim this profile
1
Article
416
Reads on Journament
30
Co-authors
1
Journal

This page collects the articles indexed under the name Albert Oriol. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.

Publications 1

  1. Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
    the lancet oncology 2016 416 reads Josep Carreras Leukaemia Research Institute

Possible papers by Albert Oriol 4

Published under a similar spelling of the name. Beside each paper is the evidence that it may be the same person, strongest first; "Same name only" means there is nothing else to go on.

  1. Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial
    as Oriol A blood cancer journal 2021
    Same name only
  2. Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
    as Oriol A The Lancet. Oncology 2021
    Same name only
  3. Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma
    as Oriol A The New England journal of medicine 2014
    Same name only
  4. Saccharomyces cerevisiae septicemia in a patient with myelodysplastic syndrome
    as Oriol A American journal of hematology 1993
    Same name only

Under these spellings

Same person? Claim this profile, then add these papers one by one or combine a whole spelling.

Is this you?

Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.

Also published as

Tick the other spellings that are you. Leave the rest.

An admin reviews every claim. Your account's name, email address and affiliation are shown to them too.

You need an account to claim. No password: we email you a sign-in link, and your claim is sent as soon as you are back.

Institutions on these papers

  • Josep Carreras Leukaemia Research Institute · ES 1

From OpenAlex, for papers with a DOI.

Frequent co-authors

Publishes in